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Introduction
The skin and underlying soft tissues are comprised of the
epidermis (in external contact), dermis, subcutaneous fat
(adipose) tissue, fascia and muscles. Since anaerobes are
bacteria that grow in oxygen-free (anaerobic) environ-
ments, as to skin and soft tissue infections, these bacteria
are involved in infections of fascia and muscle at deep sites
of the skin, where oxygen concentrations are lower than in
superﬁcial sites.
Pathogenesis
No deﬁnite systematic classiﬁcation of skin and soft tissue
infections with anaerobic bacteria has yet been established.
In a narrow sense, however, these infections are classiﬁed
into two types according to the presence/absence of aerosis,
i.e., gas gangrene and necrotizing fasciitis. The former
condition is classiﬁed into infection with Clostridium
(clostridial type) versus bacteria other than Clostridium
(non-clostridial type) according to causative bacteria [1].
Necrotizing fasciitis is classiﬁed into type I (polymicrobial
necrotizing fasciitis), i.e., mixed infections with anaerobic
bacteria, and type II due to group A b-hemolytic Strepto-
coccus (Table 1). In actuality, there are some cases with
both gas gangrene and necrotizing fasciitis (double cases).
The main causative bacteria are C. perfringens, Pepto-
streptococcus anaerobius and Bacteroides fragilis. Cul-
tures yielding a single type of anaerobic bacteria are rare.
Genus Staphylococcus and genus Streptococcus show
symbiosis with anaerobic bacteria, and mixed infection of
either genus Staphylococcus or genus Streptococcus with
anaerobes occurs in most cases.
Necrotizing fasciitis is described in detail in other
sections.
Classiﬁcation
Infection with gas-generating anaerobes (gas gangrene)
Gas gangrene is classiﬁed into infections with Clostridium
(clostridial type) and those with bacteria other than
Clostridium (non-clostridial type) [2]. The frequency of
clostridial gas gangrene was previously high, but in recent
years that of non-clostridial gas gangrene has tended to
increase [3].
Clostridial gas gangrene This disease is a clostridial
infection with gas-generating clostridia, and is also called
‘‘clostridial myonecrosis’’ [4]. There are 6 species of
causative bacteria: C. perfringens (Welch bacillus),
C. novyi, C. histolyticum, C. sporogenes, C. septicum and
C. fallax. The incidence of infection with C. perfringens is
the highest (80–95%) [2].
With regard to predisposing factors, the majority of
these diseases are due to trauma; the disease manifests
secondary to an operative, dermal sutures removal or
contaminated wound, and also after tonsillectomy or
abortion [3]. The latent period is 6 h to 2 days. The com-
mon sites of occurrence are the lower extremities. These
infections can also develop in the upper extremities, gluteal
region, external pudendal region and the neck.
Clinical symptoms include severe pain at the affected
site as a local ﬁnding, redness, swelling, dark purple dis-
coloration, necrosis, ﬂuctuation and blistering. Subcutane-
ous crepitation is palpable. When gas is present at a
shallow skin site, rattles and ﬁne crackles are recognizable.
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When the wound is incised, serous and/or bouillon-like pus
is recognized. It has a speciﬁc strong putrid ﬂesh smell.
Remarkable generalized symptoms, as follows, are
associated with this disease: hyperthermia, arthralgia,
muscle pain, nausea/vomiting, general malaise, delirium
and shock. The clostridial type produces exotoxins leading
to thrombus formation, and can cause disseminated intra-
vascular coagulation (DIC) and shock.
On examination, gas bubbles in tissue is demonstrated
by X-ray or computed tomography (CT). Gas bubbles in
the deep muscle layer produces a feather-like invasion
pattern on X-ray images [2]. Clinical laboratory data show
leukocytosis with a nuclear shift to the left, extremely
increased C-reactive protein (CRP), increased blood sedi-
mentation, and liver dysfunction. The spread of inﬂam-
mation from fascia to muscles lead to increasing CPK or
aldorase value, and sepsis, DIC and shock may develop
from renal failure due to rhabdomyolysis [5].
To investigate causative bacteria, Gram staining and
microscopy of smear preparations from pus and necrotic
tissue must be conducted immediately as bacteriological
tests. The presence of spores with Gram-positive bacilli
strongly suggests the clostridial type. Since anaerobic
culture takes several days, treatment should be started early
without waiting for culture results.
Some reports have shown the mortality rate to be 7–25%
[2, 4].
Non-clostridial gas gangrene This is gas gangrene due to
non-clostridial infections with anaerobes. The causative
bacteria are obligate anaerobes including B. fragilis,
Porphyromonas asaccharolytica, Peptostreptococcus an-
aerobius and Eggerthella lenta. In mixed infections with
facultative anaerobes, Streptococcus pyogenes, Escherichia
coli, Klebsiella species, Proteus species and Staphylococ-
cus aureus are included.
Table 1 Classiﬁcation of skin and soft tissue infections with anaerobic bacteria
Gas gangrene Necrotizing fasciitis
Clostridial Non-clostridial Type I (polymicrobial
fasciitis)
Type II (streptococcal
gangrene)
Causative bacteria Mixed infections with
Clostridium species and
other bacteria
Mixed infections with Bacteroides
species, Escherichia coli,
Streptococcus species, etc.,
which include anaerobic bacteria
Obligate and facultative
anaerobes
Group A b-hemolytic
Streptococcus
Underlying diseases Trauma (contaminated
wound, etc.) in most cases
Diabetes mellitus in many cases Diabetes mellitus,
obesity, alcoholism,
etc.
Absence of underlying
diseases in many cases
Progression of
symptoms
Rapid Slow Slow Rapid
Inﬂammatory tissue
morphology
Myositis, muscular necrosis Fascia, skin and subcutaneous tissue Fascia, muscles Skin and subcutaneous
tissue, fascia, muscles
Dermal symptoms Local pain, redness,
swelling, blister
formation,
dark purple discoloration,
necrosis, and ﬂuctuation
Local pain, redness, swelling,
blister formation, dark purple
discoloration, necrosis, and
ﬂuctuation
Local pain, redness,
swelling, blister
formation, dark purple
discoloration and
necrosis
Marked edema, marked
erythema, blister,
hemorrhage, well-
demarcated necrosis,
ulcer
Fine crackles and
crepitation
+ + - -
Properties of pus/
malodorous
Serous, smell of putrid ﬂesh Purulent, putrid smell Purulent, malodorous (+) Serous, malodorous (-)
Bacterial microscopic
ﬁndings
Gram-positive bacilli Gram-negative bacilli and Gram-
positive cocci
Gram-positive cocci Gram-positive cocci
Blood examination
and
urinalysis ﬁndings
Anemia, jaundice,
hemoglobinuria, elevated
creatine phosphokinase
(CPK)
General inﬂammatory ﬁndings,
Diabetes mellitus
General inﬂammatory
ﬁndings
General inﬂammatory
ﬁndings, elevated anti-
streptolysin O (ASO)
X-ray ﬁndings Aerosis shows feathering
pattern in the muscle layer
on imaging
Image of subcutaneous aerosis Gas (-) Gas (-)
Hyperbaric oxygen
therapy
Markedly effective Ineffective Ineffective Ineffective
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Diabetes mellitus is associated with diseases due to
these pathogens in many cases, with a frequency of 60%
among all cases. Other conditions associated with these
pathogens include decubitus ulcers, carcinomas, pilonidal
sinus and hidradenitis suppurativa [6]. These infectious
diseases also develop in many patients with liver
cirrhosis.
The local ﬁndings and general symptoms are generally
similar to those of clostridial gas gangrene; the disease
spreads rapidly to reach the deep fascia. Superﬁcial
swelling, ﬁne crackles and crepitation manifest. When the
wound is incised, gas bubbles are revealed. The discharge
obtained by incision and drainage is purulent. In the case
of infection with B. fragilis, the discharge smells like
feces. In the case of infection with P. anaerobius, the
discharge is a yellowish pus which smells like fetid mud
[3].
Examination ﬁndings of the disease are also similar to
those for clostridial gas gangrene, but gas bubbles rarely
spreads to muscles in non-clostridial gas gangrene. Mixed
infections with Streptococcus species may lead to the
rapid spread of phlegmon and cause streptococcal
gangrene.
In a manner similar to that for clostridial gas gan-
grene, Gram staining and microscopy of smear prepara-
tions from pus and necrotic tissue must be conducted
immediately to identify the causative bacteria. When the
causative bacteria are members of genus Bacteroides,
which are small Gram-negative bacilli, being overlooked
is likely because they blend into the background [7].
Since culture takes at least 2 days, treatment should be
started immediately in suspected cases without waiting
for culture results.
The prognosis of this disease is considered to be worse
than that of clostridial gas gangrene; the morbidity rate is
believed to be 30–40%.
Anaerobic infections without characteristic gas generation
Necrotizing fasciitis (for details, refer to other sec-
tions) This is the most serious infection leading to
necrosis of the skin and soft tissue with cardiovascular
disturbances. It is classiﬁed into type I (polymicrobial
fasciitis: causative bacteria are obligate and facultative
anaerobes) and type II [streptococcal gangrene: severe
infection with group A b-hemolytic Streptococcus leading
to sudden septic shock, DIC, adult respiratory distress
syndrome (ARDS), and multiple organ failure] [1, 8].
Causative bacteria
The main causative bacteria of skin and soft tissue anaer-
obic infections are listed in Table 2.
Bacteroides species includes small anaerobic Gram-
negative bacilli. B. fragilis is an anaerobe with relatively
high aerotolerance, and even when left untreated for
3 days, some cells remain alive [7]. This resistance to
oxygen (the aerotolerant state) is considered to be related to
the pathogenicity of Bacteroides species.
Clostridium species includes obligate anaerobic Gram-
positive bacilli. They exist in soil and animal feces, and
most are non-pathogenic. Most infections with these bac-
teria develop after injury. The bacteria frequently cause
infections from the gastrointestinal tract and skin at the
injury site. Infections with these bacteria develop from
intramuscular injections, surgical and dermal sutures-out
wounds, after abortion, with rectal cancer, and from foreign
bodies in the rectum [4]. Six species of clostridia, C. per-
fringens (Welch bacillus), C. novyi, C. histolyticum,
C. sporogenes, C. septicum and C. fallax, are believed to
possess pathogenicity. C. perfringens is among the resident
ﬂora of the lower gastrointestinal tract. C. perfringens
Table 2 Main anaerobic
bacteria causing skin and soft
tissue infections
Clostridium species C. perfringens (Welch bacillus)
C. novyi
C. histolyticum
C. sporogenes
C. septicum
C. fallax
Anaerobic bacteria other than Clostridium species Bacteroides fragilis
Porphyromonas asaccharolytica
Peptostreptococcus anaerobitus
Feingoldia magna
Eggerthella lenta
Prevotella species
Fusobacterium species
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produces exotoxins, i.e., toxins a, j, l and h (phospholi-
pase C, hemolytic action, collagenase, hyaluronidase), and
thereby induces hemolysis, hematogenous disorders and
tissue damage. The most important exotoxin is toxin a [4].
P. anaerobius is a Gram-positive anaerobic coccus.
Other bacteria, which are involved in the pathogenesis
of this disease, include Finegoldia (Finegoldia magna),
Parvimonas (Parvimonas micra, previously Micromonas),
Peptoniphilus (Peptoniphilus asaccharolyticus), Prevotella
species and Fusobacterium species.
Treatment
The important therapeutic methods for skin and soft tissue
infections with anaerobic bacteria are:  Management of
general condition; ` wound opening and removal
(debridement) of necrotic tissue; and ´ administration of
antimicrobial agents. The antimicrobial agents will be
described later.
Management of general condition
At the intensive care unit (ICU), etc., where general con-
ditions can be managed, a route is secured for ﬂuid
replacement. Vital signs are checked, and respiration,
heartbeat and blood pressure are constantly monitored.
Wound opening and removal (debridement) of necrotic
tissue
When progression is rapid and the patient’s general con-
dition is poor, surgical treatment by debridement is per-
formed under anesthesia in the operating room to rapidly
counter this condition. Debridement begins with a longi-
tudinal incision [9]. According to the affected sites and
depths of infection, plastic surgery, surgery and orthopedic,
as well as dermatology, consultations are required. It is
important to remove the environment fostering anaerobic
multiplication and to thoroughly remove the necrotic tis-
sue, pus and any foreign bodies in the wound. Adminis-
tration of antimicrobial agents, regional cleansing with
physiological saline solutions including antiseptic solu-
tions, and discharge with a drain inserted are necessary for
wound management. When the wound is stable, skin
grafting is undertaken at the affected site 1–2 weeks after
these procedures.
Administration of antimicrobial agents
Details of antimicrobial drug administration will be
described later.
Oxygen under high pressure (OHP) therapy
Since anaerobic bacteria are harmed by oxygen, oxygen is
very effective for gas gangrene. Oxygen is essential for the
treatment of clostridial gas gangrene, while it is less
effective for non-clostridial gas gangrene [4]. Transporta-
tion of patients with clostridial infections to institutions
equipped with OHP should also be considered.
Antimicrobial therapy
When causative bacteria are identiﬁed by Gram staining
and anaerobic culture, the antimicrobial drugs used are re-
examined, and changed to other agents to which the iso-
lated bacteria are susceptible. With regard to skin and soft
tissue infections with anaerobic bacteria, it is rare for these
infections to involve a single type of anaerobe. Most of
these infections involve multiple bacteria. It is therefore
desirable to administer antimicrobial drugs with broad
spectra, covering these bacteria [10]. Skin and soft tissue
infections with anaerobic bacteria are serious diseases with
a high possibility of taking a fatal course. The drugs are
frequently administered by non-approved dosage regimens.
Fundamentally, many anaerobic bacteria isolated from
skin and soft tissue infections are sensitive to the penicil-
lins. Therefore, penicillins are effective against these
bacteria. High dose administration of PCG is suggested. In
actual clinical settings, piperacillin (PIPC) is administered
at a dose of 2 g, 4 times, and a tazobactam/piperacillin
(TAZ/PIPC) combination, at a dose of 4.5 g, also 4 times.
In the presence of mixed infections, second-generation
cephems with broad antibacterial spectra are used
additionally.
Clostridial gas gangrene
PIPC (2 g 9 4/day) and a TAZ/PIPC combination (4.5 g 9
4/day) are administered intravenously. For C. perfringens
infections, ampicillin (ABPC) (2 g 9 4/day) or sulbactam/
ampicillin (SBT/ABPC) combination (3 g 9 4/day) is
administered intravenously.
Non-clostridial gas gangrene
For P. anaerobicus infections, PIPC (2 g 9 4/day) and a
TAZ/PIPC combination (4.5 g 9 4/day) are administered
intravenously. B. fragilis shows natural resistance to
aminoglycosides and cotrimoxazoles, and the efﬁcacy of
ﬂuoroquinolones is also low when these bacteria are
the causative microorganisms. Therefore, SBT/ABPC
(3 g 9 4/day), as well cefmetazole (CMZ), ﬂomoxef
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(FMOX) and ceftazidime (CAZ), administered at a dose of
2 g, 3–4 times a day, are effective.
As combined therapy, clindamycin (CLDM) (600 mg 9
4/day) or minocycline (MINO) (200 mg 9 2/day) is also
administered intravenously.
Regardless of the types of causative bacteria, carbapen-
ems, i.e., a combination of imipenem/cilastain (IPM/CS)
(0.5 g 9 2–3/day or 1 g 9 3/day), is administered intra-
venously for severe cases. Meropenem (MEPM) is admin-
istered intravenously (0.5 g or 1 g 9 3/day).
When infectionwithmethicillin-resistant Staphylococcus
aureus (MRSA) is suspected, vancomycin (VCM) is
administered (1 g 9 2/day) [11].
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